We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




PET-Based Test Predicts Hormone Therapy Response

By MedImaging International staff writers
Posted on 24 Feb 2021
Image: Bright spots on PET indicate cancer cells responding to a one-day estrogen challenge (Photo courtesy of Farrokh Dehdashti/ WUSTL)
Image: Bright spots on PET indicate cancer cells responding to a one-day estrogen challenge (Photo courtesy of Farrokh Dehdashti/ WUSTL)
A positron emission tomography (PET)-based imaging approach can distinguish breast cancer patients unlikely to benefit from hormone therapy (HT), claims a new study.

Researchers at the Washington University (WUSTL; St. Louis, MO, USA) School of Medicine and the University of Illinois at Urbana-Champaign (UIUC; USA) hypothesized that an estradiol challenge would increase progesterone receptor (PgR) levels only in estrogen receptor (ER) positive tumors. To test this hypothesis, they conducted a trial in 43 postmenopausal women with advanced ER+ breast cancer of the uptake of 21-[18F]fluorofuranylnorprogesterone (FFNP, a progestin analog), before and after a one-day estradiol challenge.

The results showed 100% sensitivity and specificity to the estradiol challenge. Post-challenge increase in tumor FFNP uptake was seen in the 28 women with clinical benefit from HT (the responders), but not in the 15 others without clinical benefit (non-responders), indicating that change in tumor FFNP uptake can predict the response to HT in women with ER+ breast cancer. Six-month results also showed significantly longer survival rates in the responding subjects. The study was published on February 2, 2021, in Nature Communications.

“If breast cancer in a patient is estrogen receptor-positive, doctors will usually recommend hormone therapy, even though they know it will only work for slightly more than half the patients,” said senior author Professor Farrokh Dehdashti, MD, of WUSTL. “We observed 100% agreement between the response to estrogen challenge and the response to hormone therapy, even though the participants were on a variety of treatment regimens. This method could provide valuable information to oncologists deciding how best to treat their patients.”

PET is a nuclear medicine imaging technique that produces a 3D image of functional processes in the body. The system detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide tracer, such as FFNP. Tracer concentrations within the body are then constructed in 3D by computer analysis.

Related Links:
Washington University
School of Medicine and the University of Illinois at Urbana-Champaign


X-ray Diagnostic System
FDX Visionary-A
Multi-Use Ultrasound Table
Clinton
Ultrasonic Pocket Doppler
SD1
Ultrasound-Guided Biopsy & Visualization Tools
Endoscopic Ultrasound (EUS) Guided Devices

Channels

Ultrasound

view channel
Image: The new implantable device for chronic pain management is small and flexible (Photo courtesy of The Zhou Lab at USC)

Wireless Chronic Pain Management Device to Reduce Need for Painkillers and Surgery

Chronic pain affects millions of people globally, often leading to long-term disability and dependence on opioid medications, which carry significant risks of side effects and addiction.... Read more

Nuclear Medicine

view channel
Image: The diagnostic tool could improve diagnosis and treatment decisions for patients with chronic lung infections (Photo courtesy of SNMMI)

Novel Bacteria-Specific PET Imaging Approach Detects Hard-To-Diagnose Lung Infections

Mycobacteroides abscessus is a rapidly growing mycobacteria that primarily affects immunocompromised patients and those with underlying lung diseases, such as cystic fibrosis or chronic obstructive pulmonary... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.